// App-Quantinova.ai

: ORAL ANTICOAGULATION FOR THE PREVENTION OF CARDIOGENIC THROMBO-EMBOLIC EVENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION AND NEW-ONSET ANTERIOR WALL MOTION ABNORMALITIES

Researchers

Presenter

  • Laurie-Anne Boivin Proulx

Principal Investigators

  • Fabrice Ieroncig

  • Charles Massie

  • Ismahane Ghersi

  • Philippe Simard

  • Louis Verreault-Julien

  • Lorena Rosca

  • Yahya Alansari

  • Jean-Simon Lancette

  • Gabriel Massicotte

  • Anna Nozza

  • Annabel Chen-Tournoux

  • Benoit Daneault

  • Jean-Michel Paradis

  • Jean Diodati

  • Nicolas Pranno

  • Marc Jolicoeur

  • Brian Potter

  • Guillaume Marquis-Gravel

Medical Centers

  • CHUM Research Center and Cardiovascular Center, Montreal, Canada

  • Medecine, Montreal Heart Institute, Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved